22271 ⎘
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action; Inhibitors, antagonists of enzymes
SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE
#2POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION
#3METHODS AND ABSORBENT ARTICLES FOR INHIBITING FECAL PROTEASE ACTIVITY
#4CONTROLLED DRUG RELEASE FROM ELECTROSPUN FIBERS
#5METHOD OF GENERATING 3D POROUS HYBRID PROTEIN NANOSCAFFOLD
#6EXTRACELLULAR MATRIX SHEET STRUCTURES
#7Devices for Retaining Bodily Fluids with pH Control Components
#8Methods and Products to Detect, Minimize and Treat TRAP-Related Tissue Reactions and Tissue Injury Associated With Medical Devices
#9POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION
#10ANTICOAGULANT COMPOUNDS COMPRISING CHELATING AGENTS AND CATIONIC ANTI-COAGULATION ENHANCERS AND METHODS AND DEVICES FOR THEIR USE
#11DRUG COATING, DRUG-COATED BALLOON AND PREPARATION METHOD THEREOF
#12COMPOSITIONS AND METHODS FOR OBTAINING ORGANOIDS
#13PROSTHETIC VENOUS VALVES
#14METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE
#15METHODS OF TREATING JOINT DISEASE, DISORDERS, AND CONDITIONS WITH TISSUE INHIBITORS OF MATRIX METALLOPROTEINASE
#16Controlled drug release from electrospun fibers
#17HUMAN PLACENTAL TISSUE GRAFT PRODUCTS, METHODS, AND APPARATUSES
#18Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
#19Non-cellular root canal filler and non-cellular dental tissue regeneration promotion kit
#20Extracellular matrix (ECM) structures for tissue regeneration
#21Fibres, a process for producing such fibres and a wound dressing incorporating them
#22Hygienic medical devices having hydrophilic coatings and methods of forming the same
#23SUBCUTANEOUS BIODEGRADABLE RESERVOIR DEVICE
#24Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
#25Prosthetic venous valves
#26Directed stem cell recruitment
#27POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION
#28Therapy for post-traumatic osteoarthritis
#29Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing
#30Coatings for implantable devices
#31Compositions and Methods for Treatment of Cardiovascular Disorders
#32Stimulation of cartilage formation using reduced pressure treatment
#33Compositions and methods for obtaining organoids
#34Methods of treating joint disease, disorders and conditions with tissue inhibitors of matrix metalloproteinases
#35PREVENTATIVE THERAPY FOR POST-TRAUMATIC OSTEOARTHRITIS
#36NEUTRALIZING VENOMOUS BIOMACROMOLECULES
#37Wound dressing containing honey and collagen
#38Compositions and methods for reducing neointima formation
#39HUMAN PLACENTAL TISSUE GRAFT PRODUCTS, METHODS, AND APPARATUSES
#40Compositions and methods for inhibiting inflammation
#41Extracellular Matrix Structures
#42Adhesive wafer with a neutralizer matrix
#43Extracellular matrix sheet structures
#44Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
#45Cross-linked poly-E-lysine non-particulate support
#46Surgical fastener device for the prevention of ECM degradation
#47Surgical Fastener with Broad Spectrum MMP Inhibitors
#48Surgical Stapler with Controlled Healing
#49Drug delivery devices and methods of making and using same
#50Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
#51Controlled drug release from electrospun fibers
#52Systems, methods, and devices for treating a tissue site on a mammal having hair proximate the tissue site
#53Extracellular Matrix Sheet Structures
#54Moisture management for wound care
#55Implant with an bioactive coating and method for providing the same
#56Compositions and methods for treatment of cardiovascular disorders
#57Preventative therapy for post-traumatic osteoarthritis
#58Absorbent articles comprising glyceride copolymers
#59Compositions and methods for treatment of cardiovascular disorders
#60DEVICES AND METHODS FOR INHIBITING STENOSIS, OBSTRUCTION, OR CALCIFICATION OF A NATIVE HEART VALVE, STENTED HEART VALVE OR BIOPROSTHESIS
#61Directed stem cell recruitment
#62Compositions and Methods for Treatment of Cardiovascular Disorders
#63Vascular embolization device and production method therefor
#64One component fibrin glue comprising a polymerization inhibitor
#65Wound dressings for the controlled release of therapeutic agents
#66Drug-eluting stent
#67Extracellular Matrix Structures
#68Extracellular matrix sheet structures
#69Acceleration of diabetic wound healing
#70METHODS OF MODULATING BONE REMODELING
#71System and method for delivering protease inhibitors
#72Matrix metalloproteinase inhibiting adjuncts for surgical devices
#73Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
#74Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases
#75Absorbable Iron Alloy Stent
#76Systems, compositions, and methods for transplantation and treating conditions
#77Bioresorbable iron-based alloy stent
#78System and method for delivery of a protease inhibitor
#79Vascular casted prostheses and methods of forming same for treating biological tissue
#80Vascular casted prostheses and methods of forming same for treating biological tissue
#81Vascular casted prostheses and methods of forming same for treating biological tissue
#82Mesh Fiber Members and Methods for Forming and Using Same for Treating Damaged Biological Tissue
#83FIBRES, A PROCESS FOR PRODUCING SUCH FIBRES AND A WOUND DRESSING INCORPORATING THEM
#84Polymer composition and polymer material
#85Method and System for Treatment of Damaged Biological Tissue
#86Method and System for Treatment of Damaged Biological Tissue
#87Compositions and methods for reducing neointima formation
#88Extracellular matrix encasement structures and methods
#89Extracellular matrix encasement structures and methods
#90Extracellular matrix encasement structures and methods
#91Extracellular matrix encasement structures and methods
#92Compositions and Methods for the Prevention and Treatment of Osteolysis and Osteoporosis
#93Reinforced Prosthetic Tissue Valves
#94Method and system for treatment of cardiovascular disorders
#95Method and system for treatment of cardiovascular disorders
#96Method and system for treatment of cardiovascular disorders
#97Extracellular matrix encasement structures and methods
#98Drug delivery devices and methods of making and using same
#99Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
#100Compositions and methods for treatment of cardiovascular disorders
#101Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
#102One component fibrin glue comprising a polymerization inhibitor
#103Coated stent comprising an HMG-CoA reductase inhibitor
#104Extracellular matrix encasement structures and methods
#105Wound dressings for the controlled release of therapeutic agents
#106Reinforced vascular protheses
#107Reinforced vascular prostheses
#108Reinforced vascular prostheses
#109Wound dressing containing saccharide and collagen
#110Systems, compositions, and methods for transplantation and treating conditions
#111PAR-1 activation by metalloproteinase-1 (MMP-1)
#112Local vascular delivery of sirolimus to prevent restenosis following vascular injury
#113Cross-linked poly-E-lysine non-particulate support
#114Methods of modulating bone remodeling
#115Liquid and low melting coatings for stents
#116Method and system for treatment of cardiovascular disorders
#117Increasing survival of free tissue grafts and flaps using phosphodiesterase type 5 (PDE5) inhibitors
#118Systems, methods, and devices for treating a tissue site on a mammal having hair proximate the tissue site
#119Local vascular delivery of probucol in combination with sirolimus
#120Smart, self-decontaminating polymer and method for inhibiting the growth of a bacteria and fungus
#121Stimulation of cartilage formation using reduced pressure treatment
#122Porous calcium phosphate bone material
#123Ankle and foot bone growth compositions and methods
#124DRUG DELIVERY FROM EMBOLIC AGENTS
#125Drug delivery from rapid gelling polymer composition
#126Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stents
#127METHODS AND APPARATUS FOR TREATMENT OF ANEURYSMAL TISSUE
#128Production of polyurethane foams
#129DRUG DELIVERY FROM EMBOLIC AGENTS
#130LOCAL VASCULAR DELIVERY OF ADENOSINE A2A RECEPTOR AGONISTS IN COMBINATION WITH OTHER AGENTS TO REDUCE MYOCARDIAL INJURY
#131PAR-1 Activation by Metalloproteinase-1 (MMP-1)
#132Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
#133Medical Devices, Wound Dressings, and Methods for Dressing Wounds
#134Methods of treatment with Syk inhibitors
#135HAEMOSTATIC WOUND CARE ARTICLE
#136Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
#137Novel Regulators of the Innate Immune System
#138Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
#139Compositions and Methods for the Treatment of Skeletal Metastatic Lesions and Fractures
#140Renal tissue regeneration
#141ARTICLES FORMED BY MANUFACTURING PROCESSES, SUCH AS THREE-DIMENSIONAL PRINTING, INCLUDING SOLVENT VAPOR FILMING AND THE LIKE
#142Liquid and low melting coatings for stents
#143MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
#144Drug delivery system
#145DUAL DRUG STENT
#146Topical application and formulation of erythropoietin for skin wound healing
#147Drug delivery from stents
#148UTILIZATION OF MURAL THROMBUS FOR LOCAL DRUG DELIVERY INTO VASCULAR TISSUE
#149Compositions and methods for promoting the healing of tissue of multicellular organisms
#150Drug delivery from stents
#151SILK STENT GRAFTS
#152Angiogenesis Mechanism and Method, and Implantable Device
#153DENTINOGENESIS PROMOTER AND DENTINOGENIC PULP-CAPPING MATERIAL
#154REDUCING FIBROSIS USING MATRIX METALLOPROTEINASE INHIBITORS
#155Wound repair composition and method
#156Systems and Methods for Treatment of Aneurysms Using Zinc Chelator(s)
#157Wound healing
#158DECELLULARIZATION AND RECELLULARIZATION APPARATUSES AND SYSTEMS CONTAINING THE SAME
#159Inhibition of mitogen-activated protein kinases in cardiovascular disease
#160DRUG DELIVERY COATING FOR USE WITH A MEDICAL DEVICE AND METHODS OF TREATING VASCULAR INJURY
#161METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
#162DRUG DELIVERY COATING FOR USE WITH A MEDICAL DEVICE AND METHODS OF TREATING VASCULAR INJURY
#163Odor Blocking Water-Absorbent Compositions
#164Oligopeptides as coating material for medical products
#165Use of Phosphodiesterase Inhibitor as a Component of Implantable Medical Devices
#166DRUG DELIVERY FROM RAPID GELLING POLYMER COMPOSITION
#167Wound healing
#168BIOMEDICAL FOAM ARTICLES
#169Nanoparticles Comprising a PDGF Receptor Tyrosine Kinase Inhibitor
#170Protease inhibitors in absorbent articles
#171POLYURETHANE FOAMS FOR WOUND MANAGEMENT
#172INHIBITORS OF PHOSPHATASES
#173Liquid and low melting coating for stents
#174Medical Devices and Coatings Therefor
#175Method of production of artificial skin
#176SPACING DEVICES FOR RELEASING ACTIVE SUBSTANCES IN THE PARANASAL SINUS
#177Platelet Gel for Treatment of Aneurysms
#178Method to treat and prevent posterior capsule opacification
#179Pain-sensitive therapeutic wound dressing
#180Bone graft comprising a demineralized bone matrix and a stabilizing agent
#181Use of biocompatible amphiphilic polymers as an anti-inflammatory agent
#182Denatured human albumin biomaterial as dressing for burns and wounds of skin
#183Wound Care Device
#184MATRIX METALLOPROTEINASE INHIBITOR DELIVERING DEVICES
#185Manufacturing process, such as three-dimensional printing, including solvent vapor filming and the like
#186METHOD FOR CONTROLLING CELL MIGRATION ON A SURFACE
#187Endoluminal medical device for local delivery of cathepsin inhibitors, method of making and treating
#188Drug Delivery From Embolic Agents
#189Combination therapy for the treatment and improvement of scars
#190Methods, systems and reagents for tendon and ligament therapy
#191Liquid and low melting coatings for stents
#192Method for incorporation of bioactives into a porous hydrophobic polymer scaffold
#193Photoactive biocompatible coating composition
#194Wound dressing for the controlled release of therapeutic agents
#195Treatment of aneurysms with an implantable polymeric, biodegradable device incorporating a MMP inhibitor
#196Porous calcium phosphate bone material
#197Therapeutic compositions and methods
#198Manufacturing process, such as three dimensional printing, including binding of water-soluble material followed by softening and flowing and forming films of organic-solvent-soluble material
#199Pain-sensitive therapeutic wound dressings
#200Enzyme-sensitive therapeutic wound dressings
#201Bone growth compositions and methods
#202Coated stent
#203Material for promoting skin basement formation
#204Enzyme inhibiting adhesives
#205Metallic structures incorporating bioactive materials and methods for creating the same
#206Formulations for cell-schedule dependent anticancer agents
#207Medical devices to treat or inhibit restenosis
#208Metallic structures incorporating bioactive materials and methods for creating the same
#209Inhibition of mitogen-activated protein kinases in cardiovascular disease
#210Medical devices and methods for reducing localized fibrosis
#211Material for odor control
#212Autologous coatings for implants
#213Intradiscal anti-inflammatory therapy involving autologous adiponectin
#214Polymeric microbeads having characteristics favorable for bone growth, and process including three dimensional printing upon such microbeads
#215Enhanced adipose tissue
#216Use of organic compounds
#217Therapeutic blood vessel treatment
#218Multifunctional biodegradable composite and surgical implant comprising said composite
#219Glue compositions for lung volume reduction
#220Coated aneurysmal repair device
#221Intraluminal medical devices in combination with therapeutic agents
#222Methods of treatment with Syk inhibitors
#223Local vascular delivery of topotecan in combination with rapamycin to prevent restenosis following vascular injury
#224Metallic structures incorporating bioactive materials and methods for creating the same
#225Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of Type III and/or Type IV phosphodiesterases
#226Controlled release therapeutic wound dressings
#227Medical devices to treat or inhibit restenosis
#228Medical devices to treat or inhibit restenosis
#229Composition and method for bone regeneration
#230Local vascular delivery of trichostatin A alone or in combination with sirolimus to prevent restenosis following vascular injury
#231Stents and intra-luminal prostheses containing map kinase inhibitors
#232Metallic structures incorporating bioactive materials and methods for creating the same
#233Wound care device for local treatment of pain in a wound
#234Stents capable of controllably releasing histone deacetylase inhibitors
#235Drug/drug delivery systems for the prevention and treatment of vascular disease
#236Drug-coated stents and methods of use therefor